LSB
LakeShore Biopharma
LSB
LSB
Delisted
LSB was delisted on the 19th of September, 2025.
10 hedge funds and large institutions have $4.89M invested in LakeShore Biopharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
10
Holding in Top 10
1
Calls
–
Puts
–
Top Sellers
| 1 | -$667K | |
| 2 | -$286K | |
| 3 | -$271K | |
| 4 |
CAC
Cowen and Company
New York
|
-$9.88K |
| 5 |
Barclays
London,
United Kingdom
|
-$5K |